Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Eiger BioPharmaceuticals, Inc. (EIGR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
SC 13G
| Propel Bio Management, LLC reports a 5.4% stake in EIGER BioPharmaceuticals, Inc. |
| 05/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/07/2020 |
SC 13G
| BlackRock Inc. reports a 7.7% stake in EIGER BIOPHARMACEUTICALS INC |
| 06/14/2019 |
SC 13G
| Broadfin Capital, LLC reports a 6.8% stake in Eiger BioPharmaceuticals, Inc. |
| 10/26/2018 |
SC 13G
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 9.6% stake in Eiger Biopharmaceuticals, Inc. |
| 10/25/2018 |
SC 13G
| RA CAPITAL MANAGEMENT, LLC reports a 13.1% stake in Eiger BioPharmaceuticals, Inc. |
| 06/04/2018 |
SC 13G
| EcoR1 Capital, LLC reports a 7.6% stake in Eiger Biopharmaceuticals, Inc. |
| 02/05/2018 |
SC 13G
| JENNISON ASSOCIATES LLC reports a 5.8% stake in Eiger BioPharmaceuticals, Inc. |
| 01/22/2018 |
SC 13G
| PRUDENTIAL FINANCIAL INC reports a 5.8% stake in Eiger BioPharmaceuticals, Inc. |
| 11/09/2017 |
SC 13G
| Prosight Management, LP reports a 6.9% stake in EIGER BIOPHARMACEUTICALS, INC. |
| 08/22/2017 |
SC 13G
| SPHERA FUNDS MANAGEMENT LTD. reports a 5.4% stake in Eiger BioPharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/16/2016 |
SC 13G
| Lombard Odier Asset Management Corp reports a 6.1% stake in Celladon Corporation |
|
|